A Randomized Phase III Study of Pembrolizumab Versus Pembrolizumab-Carboplatin- Pemetrexed for Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer with PD-L1 50% or more (LAPLACE-50): Study Protocol

Author(s):  
Yoshihito Kogure ◽  
Hiroya Hashimoto ◽  
Masahide Oki
Sign in / Sign up

Export Citation Format

Share Document